Evolution of Polypoidal Lesions after Treatment of Polypoidal Choroidal Vasculopathy.

ABSTRACT:

Purpose

To evaluate the status and evolution of polypoidal lesions during the course of treatment of patients with symptomatic macular polypoidal choroidal vasculopathy (PCV).

Design

Comparative cohort study of randomly selected patients from a multicenter, randomized controlled clinical trial.

Participants

Thirty randomly selected patients from the EVEREST II study who were treated with combination ranibizumab and verteporfin photodynamic therapy (n = 15) or ranibizumab monotherapy (n = 15).

Methods

All patients were randomized at baseline and treated with a standardized treatment protocol. Indocyanine green angiography (ICGA) images were graded at the central reading center at baseline and months 3, 6, 12, and 24. Polypoidal lesions present at baseline were o

SUBMITTER: Tan CS 

PROVIDER: S-EPMC9560532 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature